Novartis to buy U.S. biotech The Medicines Co. for $9.7 bln

ZURICH — Novartis AG is buying U.S. biotechnology company The Medicines Co for about $ 9.7 billion, the Swiss drugmaker said on Sunday, as it seeks to expand its portfolio of medicines against cardiovascular disease. Read More
Financial Post